Tuberculosis Vaccines

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculous meningitis and miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccine’s potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

  • Scientific challenges facing the TB vaccine field
  • Next Generation TB Vaccines and Vaccine Concepts
  • TB vaccine development

Related Conference of Tuberculosis Vaccines

July 27-28, 2018

31st Annual Congress on Vaccines & Clinical Trials

Vancouver, Canada
Aug 27-29, 2018

Annual Congress and Expo on Vaccines & Immunology

Amsterdam, Netherlands
October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan

Tuberculosis Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in